SCHEMBL4598731

SCHEMBL4598731

O=S(=O)(Oc1cc[c]c(NCc2ccccc2)c1)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
FAAH O00519 2/20 0.41
TDP1 Q9NUW8 3/20 0.40
KEAP1 Q14145 1/20 0.39
MAOB P27338 2/20 0.39
CA12 O43570 3/20 0.38
CA2 P00918 3/20 0.38
CA7 P43166 1/20 0.38
CA14 Q9ULX7 1/20 0.38
CA1 P00915 2/20 0.38
CA9 Q16790 2/20 0.38
HTT P42858 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.36
GAA P10253 1/20 0.36
MAPK1 P28482 1/20 0.36
LMNA P02545 1/20 0.36
F2 P00734 1/20 0.35
TP53 P04637 1/20 0.35
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4599999 0.92 L3MBTL1 (0.45) ALDH1A1SMN1; SMN2TDP1CA12CA9
SCHEMBL4599161 0.91 HTT (0.49) ALDH1A1SMN1; SMN2TDP1KEAP1CA12
SCHEMBL4611281 0.87 FAAH (0.40) ALDH1A1SMN1; SMN2FAAHTDP1MAOB
SCHEMBL4598688 0.85 TDP1 (0.43) ALDH1A1SMN1; SMN2FAAHTDP1MAOB
SCHEMBL4599391 0.85 HTT (0.40) ALDH1A1SMN1; SMN2FAAHCA12CA2
SCHEMBL4599760 0.82 ALDH1A1 (0.40) ALDH1A1SMN1; SMN2FAAHTDP1MAOB
SCHEMBL4600500 0.81 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2TDP1MAOBCA12
SCHEMBL4599861 0.80 GAA (0.40) ALDH1A1CA12CA9HTTL3MBTL1
SCHEMBL4599252 0.80 ALDH1A1 (0.51) ALDH1A1SMN1; SMN2TDP1MAOBCA12
SCHEMBL4610582 0.80 ALDH1A1 (0.45) ALDH1A1SMN1; SMN2TDP1HTTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1910320-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF Mitsubishi Tanabe Pharma Corporation (JP) 2008-04-16 EP claimed
WO-2007011065-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF MITSUBISHI TANABE PHARMA CORPORATION (JP) 2007-01-25 WO claimed
EP-1910320-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF Mitsubishi Tanabe Pharma Corporation (JP) 2008-04-16 EP disclosed
WO-2007011065-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF MITSUBISHI TANABE PHARMA CORPORATION (JP) 2007-01-25 WO disclosed